Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,302 papers from all fields of science
Search
Sign In
Create Free Account
Substrate Deprivation Therapy
Known as:
Substrate Reduction Therapy
A therapeutic procedure based on the inhibition or reduction of the biosynthesis of compounds that cannot break down in the cells.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Effect of eliglustat on the pharmacokinetics of digoxin, metoprolol, and oral contraceptives and absorption of eliglustat when coadministered with acid-reducing agents.
N. Thibault
,
J. Ibrahim
,
+5 authors
S. Turpault
Molecular Genetics and Metabolism
2020
Corpus ID: 211044789
2014
2014
Bone disease in patients with Gaucher disease
B. Rosenbloom
,
N. Weinreb
Expert Review of Endocrinology & Metabolism
2014
Corpus ID: 71589306
Gaucher disease is an inborn error of metabolism due to a deficiency of the lysosomal enzyme glucocerebrosidase. As a result of…
Expand
Review
2013
Review
2013
Therapeutic approaches for lysosomal storage diseases: a patent update.
L. Urbanelli
,
K. Sagini
,
M. Polidoro
,
Alessandro Brozzi
,
A. Magini
,
C. Emiliani
Recent Patents on CNS Drug Discovery
2013
Corpus ID: 6968163
Lysosomal Storage Diseases (LSDs) are inherited metabolic disorders caused by specific lysosomal protein deficiencies, which lead…
Expand
2010
2010
Changes in the atherogenic profile of patients with type 1 Gaucher disease after miglustat therapy.
J. Puzo
,
P. Alfonso
,
P. Irún
,
J. Gervas
,
M. Pocovi
,
Pilar Giraldo
Atherosclerosis
2010
Corpus ID: 35715442
2009
2009
A new surrogate marker for CNS pathology in Niemann-Pick disease type C?
F. Platt
,
R. Lachmann
Molecular Genetics and Metabolism
2009
Corpus ID: 19368175
Review
2007
Review
2007
Update on treatment of lysosomal storage diseases.
S. Bruni
,
L. Loschi
,
C. Incerti
,
O. Gabrielli
,
G. Coppa
Acta myologica
2007
Corpus ID: 22252215
Lysosomal storage diseases (LSDs) are a large group of disorders caused by a deficiency of specific enzymes responsible for the…
Expand
Review
2007
Review
2007
Therapy for Gaucher disease: don't stop thinking about tomorrow.
E. Sidransky
,
M. Lamarca
,
E. Ginns
Molecular Genetics and Metabolism
2007
Corpus ID: 30454167
Review
2007
Review
2007
[Current development and usefulness of biomarkers for Gaucher disease follow up].
I. Maire
,
N. Guffon
,
R. Froissart
La Revue de medecine interne
2007
Corpus ID: 30136703
2006
2006
Clinical experience with substrate reduction therapy.
A. Mehta
European journal of internal medicine
2006
Corpus ID: 10395301
2005
2005
Newborn screening for lysosomal storage disorders.
D. Millington
Clinical Chemistry
2005
Corpus ID: 13524812
The concept of screening newborns for inherited metabolic disorders was the brainchild of Robert Guthrie, an upstate New York…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE